Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q3 2024 | 6 | $463M | +$113M | -$935K | +$112M | GTX, SATS, YNDX | 13F-HR | 11/14/2024, 04:10 PM |
Q2 2024 | 4 | $367M | +$82.4M | -$51.4M | +$31M | GTX | 13F-HR | 8/14/2024, 04:28 PM |
Q1 2024 | 8 | $371M | +$16.1M | -$64.2M | -$48M | GTX, OSG, HA, ICMB, INSW | 13F-HR | 5/15/2024, 04:55 PM |
Q4 2023 | 8 | $419M | +$66.3M | -$102M | -$35.5M | GTX, INSW, OSG, HA, SAVE | 13F-HR | 2/14/2024, 04:17 PM |
Q3 2023 | 7 | $392M | $0 | -$133M | -$133M | GTX, SAVE, INSW, OSG, ICMB | 13F-HR | 11/14/2023, 04:27 PM |
Q2 2023 | 8 | $510M | +$204M | -$223M | -$19M | GTX, DEN, SAVE, OSG, INSW | 13F-HR | 8/14/2023, 04:04 PM |
Q1 2023 | 9 | $528M | +$38.1M | -$12.6M | +$25.5M | GTXAP, DEN, GTX, SAVE, INSW | 13F-HR | 5/15/2023, 04:13 PM |
Q4 2022 | 8 | $487M | +$374K | -$22.5M | -$22.1M | GTXAP, DEN, GTX, INSW, OSG | 13F-HR | 2/14/2023, 04:26 PM |
Q3 2022 | 7 | $450M | $0 | -$35.3M | -$35.3M | GTXAP, DEN, GTX, INSW, OSG | 13F-HR | 11/14/2022, 05:04 PM |
Q2 2022 | 7 | $458M | $0 | -$57.8M | -$57.8M | GTXAP, DEN, GTX, INSW, OSG | 13F-HR | 8/15/2022, 11:33 AM |
Q1 2022 | 9 | $538M | +$32.9M | -$3.94M | +$29M | GTXAP, DEN, GTX, INSW, ICMB | 13F-HR | 5/16/2022, 02:55 PM |
Q4 2021 | 10 | $502M | +$199M | -$40.4M | +$159M | GTXAP, DEN, GTX, INSW, OSG | 13F-HR | 2/14/2022, 04:19 PM |
Q3 2021 | 10 | $343M | +$1.37M | -$21.4M | -$20M | DEN, GTX, INSW, OSG, ICMB | 13F-HR | 11/15/2021, 04:05 PM |
Q2 2021 | 11 | $386M | +$81.8M | -$173M | -$90.8M | DEN, GTX, INSW, ICMB, OSG | 13F-HR | 8/16/2021, 04:07 PM |
Q1 2021 | 12 | $381M | +$16.2M | -$109M | -$93.1M | DEN, PCG, INSW, ICMB, LILAK | 13F-HR | 5/17/2021, 04:28 PM |
Q4 2020 | 12 | $421M | +$6.66M | -$124M | -$118M | PCG, DEN, INSW, OSG, ICMB | 13F-HR | 2/16/2021, 04:50 PM |
Q3 2020 | 14 | $428M | +$137M | -$6.52M | +$130M | PCG, DEN, INSW, OSG, ICMB | 13F-HR | 11/16/2020, 03:59 PM |
Q2 2020 | 12 | $291M | +$148M | -$102M | +$46.2M | PCG, INSW, OSG, ICMB, UNIT | 13F-HR | 8/14/2020, 04:03 PM |
Q1 2020 | 13 | $272M | +$56.9M | -$520M | -$463M | INSW, AAL, LBTYK, PCG, OSG | 13F-HR | 5/15/2020, 04:10 PM |
Q4 2019 | 32 | $859M | +$345M | -$288M | +$56.8M | LQD, DAL, INSW, AAL, THC | 13F-HR | 2/14/2020, 04:03 PM |
Q3 2019 | 21 | $701M | +$68.5M | -$170M | -$101M | UAL, DAL, INSW, THC, AAL | 13F-HR | 11/14/2019, 04:06 PM |
Q2 2019 | 17 | $840M | +$183M | -$211M | -$28.5M | UAL, DAL, ALLY, LBTYK, INSW | 13F-HR | 8/14/2019, 04:07 PM |
Q1 2019 | 22 | $824M | +$169M | -$45.5M | +$124M | UAL, ALLY, AAL, DAL, INSW | 13F-HR | 5/15/2019, 04:14 PM |
Q4 2018 | 14 | $670M | +$2.56M | -$117M | -$115M | UAL, DAL, ALLY, INSW, AAL | 13F-HR | 2/14/2019, 04:04 PM |
Q3 2018 | 23 | $908M | +$20.8M | -$278M | -$257M | UAL, DAL, ALLY, INSW, CRCQQ | 13F-HR | 11/14/2018, 04:31 PM |
Q2 2018 | 17 | $1.08B | +$305M | -$151M | +$154M | AET, UAL, ALLY, DAL, INSW | 13F-HR | 8/14/2018, 04:09 PM |
Q1 2018 | 13 | $893M | +$925K | -$65.2M | -$64.3M | UAL, ALLY, DAL, TWX, AAL | 13F-HR | 5/15/2018, 04:03 PM |
Q4 2017 | 18 | $970M | +$229M | -$110M | +$119M | UAL, ALLY, DAL, TWX, AAL | 13F-HR | 2/14/2018, 05:57 PM |
Q3 2017 | 14 | $772M | +$199M | -$218M | -$19.5M | ALLY, DAL, UAL, INSW, AAL | 13F-HR | 11/14/2017, 04:14 PM |
Q2 2017 | 18 | $809M | +$255M | -$450M | -$195M | ALLY, UAL, DAL, INSW, AAL | Restatement | 8/15/2017, 04:41 PM |
Q1 2017 | 18 | $988M | +$209M | -$259M | -$50.5M | UAL, DAL, ALLY, TWX, INSW | 13F-HR | 5/15/2017, 04:15 PM |
Q4 2016 | 18 | $1.03B | +$381M | -$573M | -$192M | AAL, ALLY, DAL, TWX, UAL | 13F-HR | 2/14/2017, 04:11 PM |
Q3 2016 | 20 | $1.17B | +$84.3M | -$9.83M | +$74.4M | VA, AAL, ALLY, DAL, UAL | Restatement | 12/2/2016, 04:02 PM |
Q2 2016 | 17 | $1.05B | +$109M | -$59.4M | +$49.6M | VA, ALLY, AAL, DAL, CMFN | 13F-HR | 8/15/2016, 04:03 PM |
Q1 2016 | 13 | $919M | +$55.5M | -$40.3M | +$15.2M | VA, DAL, ALLY, AAL, CMFN | 13F-HR | 5/16/2016, 04:02 PM |
Q4 2015 | 11 | $917M | +$35.4M | -$72.9M | -$37.6M | VA, DAL, ALLY, AAL, CMFN | 13F-HR | 2/16/2016, 04:02 PM |
Q3 2015 | 15 | $938M | +$170M | -$284M | -$114M | VA, DAL, ALLY, AAL, SPB | 13F-HR | 11/16/2015, 04:02 PM |
Q2 2015 | 17 | $1.09B | +$101M | -$63.1M | +$37.4M | VA, ALLY, AAL, SPB, CRC | 13F-HR | 8/14/2015, 04:21 PM |
Q1 2015 | 17 | $1.12B | +$320M | -$272M | +$48.4M | VA, ALLY, AAL, CRC, DAL | 13F-HR | 5/15/2015, 04:03 PM |
Q4 2014 | 22 | $1.23B | +$715M | -$285M | +$429M | VA, DAL, ALLY, SPB, LBTYK | 13F-HR | 2/17/2015, 04:01 PM |
Q3 2014 | 16 | $731M | +$22M | -$245M | -$223M | SPB, DAL, AIG, CIT, ALLY | 13F-HR | 11/14/2014, 04:01 PM |
Q2 2014 | 19 | $1.04B | +$303M | -$158M | +$145M | AIG, JBLU, AAL, SPB, DAL | 13F-HR | 8/14/2014, 04:14 PM |
Q1 2014 | 17 | $846M | +$265M | -$94.5M | +$170M | SPB, AIG, DAL, CIT, AAL | 13F-HR | 5/15/2014, 04:10 PM |
Q4 2013 | 16 | $646M | $0 | $0 | AIG, DAL, SPB, CIT, CHMT | 13F-HR | 2/14/2014, 02:02 PM |